Hologic (HOLX) to Acquire Gen-Probe (GPRO) in $3.7B Deal

Hologic, Inc. (NASDAQ: HOLX) to acquire Gen-Probe Incorporated (NASDAQ: GPRO) for $82.75 per share in cash, or a total enterprise value of approximately $3.7 billion.

The transaction is expected to be completed in the second half of calendar 2012.

The transaction delivers a strong growth profile with attractive economics and is expected to be $0.20 accretive to Hologic's adjusted earnings per share in the first fiscal year after close and significantly more accretive thereafter. Hologic also expects the transaction to accelerate top and bottom line growth rates. The combined company expects to realize approximately $75 million in cost synergies within three years following the close of the transaction. In addition, the combined company expects to have strong free cash flows, which will be used primarily to reduce debt with the expectation to return to pre-transaction leverage levels within three years.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
• Bernstein SocGen on Meta Platforms Inc. (META): 'Risk-reward remains attractive'
• Bernstein remains bullish on SpaceX but sees challenges in telecom ambitions